Imidex's FDA-Cleared Algorithm for Early Lung Cancer Detection Sold

Imidex's FDA-Cleared Algorithm for Early Lung Cancer Detection Sold

DENVER, April 17, 2025 /PRNewswire/ -- Imidex, a Denver-based leader in artificial intelligence for healthcare, today announced the sale of its FDA-cleared AI algorithm, VisiRad® XR, along with its associated intellectual property and annotated dataset. Financial terms of the transaction…

What is the Best Use of AI in CT Lung Cancer Screening?

In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.